MMC Pharma

Our total focus is on pharmaceutical marketing Domestic & International of our own brands.

  • 1987

    Founded by Mr. M.Rajarathinam as a partnership company viz Madras Medical Company.

  • 1988

    Tablet Manufacturing plant commenced production Domestic marketing operations started in Tamilnadu

  • 1989

    Medineuron,Medicine for treating Neurons launched.

  • 1991

    India’s first Activated Serratiopeptidase brand Septidase Launched for the management of Inflammation.

  • 1992

    Thermonil Tablets India’s 1st Dispersible Paracetamol Tablets launched.

  • 1997

    Partnership company was converted in to a Public Limited Company Viz. MMC Healthcare Ltd.

  • 1998

    Flagship brand Pileum a Phyto medicine launched for the treatment of Piles, Fissures & Fistula.

  • 2004

    New Manufacturing plant for manufacture of Tablet, capsules & Syrup started in Thirumazhisai Industrial Estate, Chennai

  • 2005

    Second manufacturing plant at Deonghat, Solan, Himachalapradesh started for manufacture of Tablets, Capsules, Syrups & Liniments.

  • 2016

    MMC Healthcare Ltd demerged as MMC Pharmaceuticals Ltd focusing on Marketing & MMC Healthcare Ltd focusing on Manufacturing. Second Marketing Division Ziva focusing on Infertility management launched.

  • 2017

    MMC enters into Respiratory care by the launch of EB(Easy Breathing)range of products. Cystop range of products for the treatment of PCOS in Gynec segment launched.

  • 2018

    Libidup & Libidup PE range of products in andrology segment launched.

  • 2019

    MMC enters into Geriatric care with the launch of Hemocare Senior.

  • 2020

    Marketing in Myanmar Wellmune range of Immuno boosters launched during the difficult COVID pandemic.

  • 2021

    Normoflora range of products for the treatment of Dysbiosis in Genito urinary tract launched.

  • 2022

    Hemocare has received award in the category of Perception that matters awarded by Pronto Consult Consumers awards, Mumbai.

  • 2023

    In April 2023 Launched our New Brand Medineuron LC For muscle cramps in Gynecology speciality EbMont BL for the treatment of allergic rhinitis in the ENT speciality

  • 2023

    In October we launched the our unique brand OvaZoa Reserve in infertility speciality

  • 2024

    Launched a vast range of infertility products like Embryo Fix for Recurrent implantation failure &Embryo FG Granules for the treatment of Fetal Growth

  • 2024

    Launched the Embryofix FG granules for exclusive for Fetal growth

  • 2024

    MMC entered into new specialty Nephrology Launched the brand Uralbu for Urinary albumin excretion